Compare Crescent Energy Company Class A Common Stock (CRGY) vs Definium Therapeutics Inc. Common Shares (DFTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Definium Therapeutics Inc. Common Shares — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.7 (market cap $4.30B), while Definium Therapeutics Inc. Common Shares trades at $37.05 (market cap $4.59B). The key difference: Crescent Energy Company Class A Common Stock and Definium Therapeutics Inc. Common Shares are close in size by market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 1 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| CRGY | DFTX | |
|---|---|---|
Market Cap | $4.30B | $4.59B |
Volume | 15,201,625 | 2,103,937 |
Sector | Energy | Health |
52-Week High | $15.37 | $48.45 |
52-Week Low | $7.75 | $10.68 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $9.31B | $3.55B |
Dividend Yield | 3.69% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →
